Cantor Fitzgerald Downgrades BioDelivery Sciences International (BDSI) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
BioDelivery Sciences Provides Corporate Update and Reports First Quarter 2016 Financial Results
May 10, 2016 7:00 AM EDTRALEIGH, N.C., May 10, 2016 /PRNewswire/ --
Strategic initiatives implemented to better align BUNAVAIL® expenses with revenue as part of ongoing efforts to preserve and enhance long-term value; changes expected to result in savings of approximately $20 million through 2017 BUNAVAIL prescriptions increase 180% compared to first quarter of 2015; over 350 new prescribers added in first quarter of 2016 BUNAVAIL net revenue increased 41% in first quarter compared to fourth quarter 2015 BUNAVAIL revenue per prescription increased more than 20% in the first quarter compared to fourth quarter 2015 Strong cash position of $69.4... More